Hematolymphoid Lesions of the Sinonasal Tract

详细信息    查看全文

• 作者：Friederike H. Kreisel
• 关键词：Sinonasal tract ; DLBCL ; Extranodal NK/T cell lymphoma ; Plasmacytoma ; Rosai–Dorfman disease
• 刊名：Head and Neck Pathology
• 出版年：2016
• 出版时间：March 2016
• 年：2016
• 卷：10
• 期：1
• 页码：109-117
• 全文大小：3,498 KB
• 参考文献：1.Grau C, Holmelund Jakobsen M, Harbo G, et al. Sino-nasal cancer in Denmark 1982–1991. A nationwide survey. Acta Oncol. 2001;40:19–23.CrossRef PubMed
  2.Harbo G, Grau C, Bundgaard T, et al. Cancer of the nasal cavity and paranasal sinuses. A clinic-pathological study of 277 patients. Acat Oncol. 1997;36:45–50.CrossRef
  3.Dubal PM, Dutta R, Vazquez A, et al. A comparative population-based analysis of sinunasal diffuse large B-cell and extranodal NK/T-cell lymphomas. Laryngoscope. 2015;125:1077–83.CrossRef PubMed
  4.Oprea C, Cainap C, Azoulay R, et al. Primary diffuse large B-cell non-Hodgkin lymphoma of the paranasal sinuses: a report of 14 cases. Br J Haematol. 2005;131:468–71.CrossRef PubMed
  5.Vega F, Lin P, Medeiros J. Extranodal lymphomas of the head and neck. Ann Diagn Pathol. 2005;9:340–50.CrossRef PubMed
  6.Cuadra-Garcia I, Proulx GM, Wu CL, et al. Sinonasal lymphoma: a clinicopathologic analysis of 58 cases from the Massachusetts General Hospital. Am J Surg Pathol. 1999;23:1356–69.CrossRef PubMed
  7.Maeshima AM, Taniguchi H, Makita S, et al. Histopathological characteristics of lymphomas in the upper aerodigestive tract: a single-institute study in Japan. J Clin Exp Hematopathol. 2015;55:7–11.CrossRef
  8.Kim GE, Koom WS, Yang W-I, et al. Clinical relevance of three subtypes of primary sinonasal lymphoma characterized by immunophenotypic analysis. Head Neck. 2004;26:584–93.CrossRef PubMed
  9.Kanumuri VV, Khan MN, Vazquez A, et al. Diffuse large B-cell lymphoma of the sinonasal tract: analysis of survival in 852 cases. Am J Otolaryngol. 2014;35:154–8.CrossRef PubMed
  10.Lee G-W, Go S-I, Kim S-H, et al. Clinical outcome and prognosis of patients with primary sinonasal tract diffuse large B-cell lymphoma treated with rituximab-cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy: a study by the consortium for improving survival of lymphoma. Leuk Lymphoma. 2015;56:1020–6.CrossRef PubMed
  11.Hans CP, Weisenburger DD, Greiner TC, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood. 2004;103:275–82.CrossRef PubMed
  12.Alizadeh AA, Eisen MB, Davis RE, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature. 2000;403:503–11.CrossRef PubMed
  13.Nyman H, Adde M, Karjalainen-Lindsberg M-L, et al. Prognostic impact of immunohistochemically defined germinal center phenotype in diffuse large B-cell lymphoma patients treated with immunochemotherapy. Blood. 2007;109:4930–5.CrossRef PubMed
  14.Chan JKC, Quintanilla-Martinez L, Ferry J, et al. Extranodal NK/T-cell lymphoma, nasal type. In: Swerdlow SH, Campo E, Harris NL, et al., editors. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: IARC Press; 2008. p. 285–93.
  15.Huang Y, de Leval L, Gaulard P. Molecular underpinning of extranodal NK/T-cell lymphoma. Best Pract Res Clin Hematol. 2013;26:57–74.CrossRef
  16.Huang Y, De Reyniès A, de Leval L, et al. Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal type. Blood. 2010;115:1226–37.PubMedCentral CrossRef PubMed
  17.D’Aguillo C, Soni RS, Gordhan C, et al. Sinonasal extramedullary plasmcytoma: a systemic review of 175 patients. Int Forum Allergy Rhinol. 2014;4:156–63.CrossRef PubMed
  18.Bachar G, Goldstein D, Brown D, et al. Solitary extramedullary plasmacytoma of the head and neck—long term outcome analysis of 68 cases. Head Neck. 2008;8:1012–9.CrossRef
  19.Sasaki R, Yasuda K, Abe E, et al. Multi-institutional analysis of solitary extramedullary plasmacytomaof the head and neck treated with curative radiotherapy. Int J Radiat Oncol Biol Phys. 2012;82:626–34.CrossRef PubMed
  20.Rajkumar SV. Multiple myeloma: 2014 update on diagnosis, risk-stratification and management. Am J Hematol. 2014;89:999–1009.
  21.Hazarika P, Balakrishnan R, Singh R, et al. Solitary extramedullary plasmacytoma of the sinonasal region. Indian J Otolaryngol Head Neck Surg. 2011;63:S33–5.CrossRef
  22.Patel TD, Vazquez A, Choudhary MM, et al. Sinonasal extramedullary plasmacytoma: a population-based incidence and survival analysis. Int Forum of Allergy Rhinol. 2015 (Epub ahead of print).
  23.Hussong JW, Perkins SL, Schnitzer B, et al. Extramedullary plasmacytoma. A form of marginal zone cell lymphoma? Am J Clin Pathol. 1999;111:111–6.PubMed
  24.Bink K, Haralambieva E, Kremer M, et al. Primary extramedullary plasmacytoma: similarities with and differences from multiple myeloma revealed by interphase cytogenetics. Hematologica. 2008;93:623–6.CrossRef
  25.Majumdar S, Raghavan U, Jones NS. Solitary plasmacytoma and extramedullary plasmacytoma of the paranasal sinuses and soft palate. J Laryngol Otol. 2002;116:962–5.CrossRef PubMed
  26.Delecluse HJ, Anagnostopoulos I, Dallenbach F, et al. Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection. Blood. 1997;4:1413–20.
  27.Dong HY, Scadden DT, de Leval L, et al. Plasmablastic lymphoma in HIV-positive patients. An aggressive Epstein–Barr virus-associated extramedullary plsamacytic neoplasm. Am J Surg Pathol. 2005;29:1633–41.CrossRef PubMed
  28.Folk GS, Abbondanzo SL, Childers EL, et al. Plasmablastic lymphoma: a clinicopathologic correlation. Ann Diagn Pathol. 2006;10:608–9.CrossRef
  29.Rosai J, Dorfman RF. Sinus histiocytosis with massive lymphadenopathy. A newly recognized benign clinicopathological entity. Arch Pathol. 1969;87:63–70.PubMed
  30.Dalia S, Sagatys E, Sokol L, et al. Rosai–Dorfman disease: tumor biology, clinical features, pathology, and treatment. Cancer Control. 2014;21:322–7.PubMed
  31.Gaitonde S. Multifocal, extranodal sinus histiocytosis with massive lymphadenopathy. Arch Pathol Lab Med. 2007;131:1117–21.PubMed
  32.Duan H-G, Zheng C-Q, Wang D-H, et al. Extranodal sinonasal Rosai–dorfman disease: a clinical study of 10 cases. Eur Arch Otorhinolaryngol. 2015;272:2313–8.CrossRef PubMed
  33.Hsiao CH, Tsai TF, Yang TH, et al. clinicopathologic characteristics of Rosai–Dorfman disease in a medical center in northern Taiwan. J Formos Med Assoc. 2006;105:701–7.CrossRef PubMed
  34.Luppi M, Barozzi P, Garber R, et al. Expression of human herpesvirus-6 antigens in benign and malignant lymphoproliferative diseases. Am J Pathol. 1998;153:815–23.PubMedCentral CrossRef PubMed
  35.Mehraein Y, Wagner M, Remberger K, et al. Parvovirus B19 detected in Rosai–Dorfman disease in nodal and extranodal manifestations. J Clin Pathol. 2006;59:1320–6.PubMedCentral CrossRef PubMed
  36.Menon MP, Evbuomwan MO, Rosai J, et al. A subset of Rosai–Dorfman disease cases exhibit increased IgG4 positive plasma cells: another red herring or a true association with IgG4 related disease? Histopathology. 2014;64:455–9.PubMedCentral CrossRef PubMed
  37.Zhang X, Hyjek E, Vardiman J. A subset of Rosai–Dorfman disease exhibits features of IgG4-related disease. Am J Clin Pathol. 2013;139:622–32.CrossRef PubMed
  38.Liu L, Perry AM, Cao W, et al. Relationship between Rosai–dorfman disease and IgG4-related disease. Study of 32 cases. Am J Clin Pathol. 2013;140:395–402.CrossRef PubMed
  
• 作者单位：Friederike H. Kreisel (1)
  
  1. Department of Pathology and Immunology, Washington University, 660 S. Euclid Ave, Box 8118, St. Louis, MO, 63110, USA
  
• 刊物主题：Pathology; Otorhinolaryngology; Oral and Maxillofacial Surgery; Dentistry;
• 出版者：Springer US
• ISSN：1936-0568

文摘

Hematolymphoid neoplasms of the sinonasal tract are rare and the majority represents non-Hodgkin lymphomas. This review will focus on morphologic, immunophenotypic, and genetic characteristics of the most common types of non-Hodgkin lymphoma, namely diffuse large B cell lymphoma and extranodal natural killer/T-cell lymphoma, nasal type, but also include the discussion of less frequent other hematolymphoid entities, such as extranodal plasmacytomas and Rosai–Dorfman disease. Keywords Sinonasal tract DLBCL Extranodal NK/T cell lymphoma Plasmacytoma Rosai–Dorfman disease